434 related articles for article (PubMed ID: 25183264)
21. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
[TBL] [Abstract][Full Text] [Related]
22. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
23. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
24. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
Ralph LJ; McCoy SI; Shiu K; Padian NS
Lancet Infect Dis; 2015 Feb; 15(2):181-9. PubMed ID: 25578825
[TBL] [Abstract][Full Text] [Related]
25. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
Jain AK
Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
27. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
[TBL] [Abstract][Full Text] [Related]
28. Use of injectable progestin contraception and risk of STI among South African women.
Pettifor A; Delany S; Kleinschmidt I; Miller WC; Atashili J; Rees H
Contraception; 2009 Dec; 80(6):555-60. PubMed ID: 19913149
[TBL] [Abstract][Full Text] [Related]
29. Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.
Boodhram R; Moodley D; Abbai N; Ramjee G
BMC Womens Health; 2019 May; 19(1):63. PubMed ID: 31068152
[TBL] [Abstract][Full Text] [Related]
30. Hormonal contraception and HIV acquisition among women: an updated systematic review.
Curtis KM; Hannaford PC; Rodriguez MI; Chipato T; Steyn PS; Kiarie JN
BMJ Sex Reprod Health; 2020 Jan; 46(1):8-16. PubMed ID: 31919239
[TBL] [Abstract][Full Text] [Related]
31. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
Balkus JE; Palanee-Phillips T; Reddy K; Siva S; Harkoo I; Nakabiito C; Kintu K; Nair G; Chappell C; Kiweewa FM; Kabwigu S; Naidoo L; Jeenarain N; Marzinke M; Soto-Torres L; Brown ER; Baeten JM
J Acquir Immune Defic Syndr; 2017 Oct; 76(2):e47-e51. PubMed ID: 28542081
[TBL] [Abstract][Full Text] [Related]
32. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
Hapgood JP; Kaushic C; Hel Z
Endocr Rev; 2018 Feb; 39(1):36-78. PubMed ID: 29309550
[TBL] [Abstract][Full Text] [Related]
33. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
Lutalo T; Musoke R; Kong X; Makumbi F; Serwadda D; Nalugoda F; Kigozi G; Sewankambo N; Sekasanvu J; Wawer M; Gray R
AIDS; 2013 Oct; 27 Suppl 1():S27-34. PubMed ID: 24088681
[TBL] [Abstract][Full Text] [Related]
34. Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa.
Smit J; Gray A; McFadyen L; Zuma K
BMC Health Serv Res; 2001; 1():4. PubMed ID: 11401729
[TBL] [Abstract][Full Text] [Related]
35. Statement on injectable contraception.
International Planned Parenthood Federation IPPF
IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
[TBL] [Abstract][Full Text] [Related]
36. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
37. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
[TBL] [Abstract][Full Text] [Related]
38. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
39. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
[TBL] [Abstract][Full Text] [Related]
40. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
Gray RH; Parker RA; Diethelm P
Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]